Discontinuation report PONSTAN
Report ID | 121303 |
Drug Identification Number | 00155225 |
Brand name | PONSTAN |
Common or Proper name | PONSTAN |
Company Name | AA PHARMA INC |
Market Status | DORMANT |
Active Ingredient(s) | MEFENAMIC ACID |
Strength(s) | 250MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100BTL |
ATC code | M01AG |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-07-28 |
Remaining supply date | 2020-07-28 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | No remaining supply |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-07-28 | English | Compare |
v2 | 2020-07-28 | French | Compare |
v3 | 2020-07-29 | English | Compare |
Showing 1 to 3 of 3